ASP Isotopes signals potential merger, targeting $300 million EBITDA by 2031

ASP Isotopes (ASPI) filed a Rule 425 communication with the SEC regarding a potential business combination. The company also submitted the notice to the Johannesburg Stock Exchange, where it maintains a secondary listing. This filing indicates active developments toward a potential merger or acquisition.

The disclosure follows the company’s inaugural Capital Markets Day held in London on September 8. Management signaled a strategic transition from the development phase to commercial production. The company set a target to achieve over $300 million in EBITDA by 2031.